tirzepatide fibrosis liver A rare case of tirzepatide-induced liver injury Tirzepatide hits two receptors. Semaglutide

Larger doses can also be used, although this increases the respective volume needed to deliver the same peptide dose per injection

The peptide accelerates healing of tendons, ligaments, muscles, and most notably for GERD sufferers, the gastrointestinal tract

NICE guidance (NG28) recommends GLP-1 receptor agonists as a treatment option for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is not effective, not tolerated or contraindicated The person has a BMI of 35 kg/m or higher (adjust accordingly for people from particular ethnic groups) and specific psychological or other medical problems associated with obesity The person has a BMI lower than 35 kg/m and insulin would have significant occupational implications, or weight loss would benefit other significant obesity-related comorbidities GLP-1 receptor agonists may also be considered in combination with insulin therapy in specialist care settings Beyond glycaemic control, specific GLP-1 receptor agonists offer significant cardiovascular benefits

Always read the product information and follow the manufacturers instructions before use